Literature DB >> 20012963

Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine.

Asuman Sengoz Inan1, Seval Masatlıoglu, Seyfi C Ozyurek, Derya Engin, Ilknur Erdem.   

Abstract

Central nervous system involvement of rheumatoid arthritis (RA) frequently develops in patients who had a long-term history of RA, irrespective of the disease activity of systemic arthritis, and it has a high mortality rate despite treatment. Since clinical symptoms and radiologic signs are rather nonspecific, in short of doing biopsy, the diagnosis of rheumatoid meningitis is one of exclusion. However, the strongly positive rheumatoid factor in the cerebrospinal fluid is quite specific. We here report a 70-year-old man who had not been diagnosed as RA before he was admitted with neurological findings, who was diagnosed as RA later and successfully treated with prednisolone and azathioprine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012963     DOI: 10.1007/s00296-009-1266-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  Rheumatoid leptomeningitis after heart transplantation.

Authors:  Jan Claassen; Edward Dwyer; Simon Maybaum; M S V Elkind
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

2.  Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab.

Authors:  R C Chou; J W Henson; D Tian; E T Hedley-Whyte; A M Reginato
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

3.  Clinical manifestations and treatment of rheumatoid pachymeningitis.

Authors:  Monika A Starosta; Sydney R Brandwein
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

4.  A case of idiopathic hypertrophic cranial pachymeningitis manifested only by positive rheumatoid factor and abnormal findings of the anterior falx.

Authors:  Motoko Kanemoto; Yasuhiro Ota; Taro Karahashi; Norio Nozue
Journal:  Rheumatol Int       Date:  2005-01-20       Impact factor: 2.631

5.  Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide.

Authors:  A E Yücel; H Kart; P Aydin; A M Ağildere; S Benli; N Altinörs; B Demirhan
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

6.  Rheumatoid meningitis: a localized immune process.

Authors:  J A Markenson; J S McDougal; P Tsairis; M D Lockshin; C L Christian
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

Review 7.  Rheumatoid meningitis: an autopsy report and review of the literature.

Authors:  Takashi Kato; Ken-ichi Hoshi; Yoshiki Sekijima; Masayuki Matsuda; Takao Hashimoto; Masako Otani; Akio Suzuki; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2003-10-02       Impact factor: 2.980

8.  Rheumatoid pachymeningitis.

Authors:  H J Tan; A A Raymond; P P Phadke; Z Rozman
Journal:  Singapore Med J       Date:  2004-07       Impact factor: 1.858

9.  Rheumatoid nodulosis of the meninges.

Authors:  N E Karam; L Roger; L L Hankins; J D Reveille
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

Review 10.  Inflammatory central nervous system involvement in rheumatoid arthritis.

Authors:  J M Bathon; L W Moreland; A G DiBartolomeo
Journal:  Semin Arthritis Rheum       Date:  1989-05       Impact factor: 5.532

  10 in total
  7 in total

Review 1.  Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.

Authors:  Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima
Journal:  Clin Rheumatol       Date:  2020-04-30       Impact factor: 2.980

Review 2.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.

Authors:  Gang Huang; Lingfeng Wu; Zhujun Mei; Dongyuan Yao
Journal:  Rheumatol Int       Date:  2022-09-20       Impact factor: 3.580

Review 4.  New insights into the impact of neuro-inflammation in rheumatoid arthritis.

Authors:  Nicholas R Fuggle; Franklyn A Howe; Rachel L Allen; Nidhi Sofat
Journal:  Front Neurosci       Date:  2014-11-06       Impact factor: 4.677

5.  Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis.

Authors:  Tomoya Shibahara; Tomonaga Matsushita; Ryu Matsuo; Yoshihisa Fukushima; Kenji Fukuda; Hiroshi Sugimori; Masahiro Kamouchi; Takanari Kitazono; Tetsuro Ago
Journal:  Case Rep Neurol       Date:  2016-07-20

Review 6.  Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms.

Authors:  Maria Sofia Basile; Rosella Ciurleo; Alessia Bramanti; Maria Cristina Petralia; Paolo Fagone; Ferdinando Nicoletti; Eugenio Cavalli
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 7.  Rheumatoid meningitis: A case report and review of the literature.

Authors:  Zhaoyi Qin; June Kim; Damian Valencia; Lames Hamoodi; Jenna Neltner; Travis Sizemore; Robert Lightfoot
Journal:  Neurol Clin Pract       Date:  2020-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.